TherapeuticsMD, Inc. Has IND Filing Accepted by FDA
The FDA accepted TherapeuticsMD Investigational New Drug application and now the Company can proceed with Phase III clinical trials for its product TX12002HR for hormone therapy.
(PRWeb August 07, 2012)
Read the full story at http://www.prweb.com/releases/2012/8/prweb9777203.htmClick here for reuse options!
Copyright 2012 Biotechblog
Comments are closed.